Search provided by
(Image Courtesy of On Target Technologies, Purdue Research Park) The technology lights up small cancer cells giving doctors a better chance to remove all the diseased tissue.
Indiana Business News
- Terre Haute to Hold Strategic Planning Event
- Grants to Support Emission Reduction Projects
- Purdue to Host Food Security Event
- IU Study Examines Program-Related Investments
- Chamber to Release 'Vision 2025' Report Card
- LaPorte Public Transit Goes Green
- Schools Score Technical Education Grants
- IWU Selects New President
- Massive Reservoir Project Receives Commission Support
updated: 10/11/2012 8:45:31 AM
Technology 'Lights Up' Cancer Cells
On Target Laboratories CEO Marty Low says the technology could also help prevent unnecessary cancer surgeries.An Indiana startup says its technology can light the way to better cancer treatment. As first reported in the Inside INdiana Business Life Sciences e-newsletter, Purdue Research Park-based On Target Laboratories is developing a way to illuminate cancer cells during surgery. The technology will allow doctors to see exactly where the cancerous tissue is and more easily remove it.
IIB Twitter Watch
The concept is from Purdue University biochemistry professor Philip Low. His previous discoveries led to the creation of Endocyte Inc. (NASDAQ: ECYT). That West Lafayette company is developing targeted biopharmaceuticals to treat cancer.
On Target Laboratories has licensed the cancer cell lighting technology from Endocyte.
Phil's brother, Marty Low is the chief executive officer of On Target Laboratories. He believes the technology will "level the playing field" by illuminating cancer cells as small as one-thousandth of a millimeter.
Source: Inside INdiana Business, On Target Technologies, Purdue Research Park
